Metraipolis › archive › dc_30bfdb89bd07

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications — Europe PMC PMID:42294342

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42294342
DOI: 10.3389/fonc.2026.1820805
License (as archived): solo-consultazione
Archived: 2026-11-01T03:47:46.200Z
SHA-256 of the archived text: c709b1b704571d7ef0774dd4501566c1e4d3a58b787ed1b0eb2ecabef70af86d
Stable URL of this page: https://metraipolis.com/documento/dc_30bfdb89bd07

How to cite

Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications — Europe PMC PMID:42294342 — Europe PMC (en), https://europepmc.org/article/MED/42294342 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_30bfdb89bd07 (Metraipolis archive dc_30bfdb89bd07, sha256 c709b1b704571d7ef0774dd4501566c1e4d3a58b787ed1b0eb2ecabef70af86d)

BibTeX

@misc{dc30bfdb89bd07,
  title = {Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications — Europe PMC PMID:42294342},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42294342},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_30bfdb89bd07; sha256 c709b1b704571d7ef0774dd4501566c1e4d3a58b787ed1b0eb2ecabef70af86d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42294342. Agents can read the archived copy with the MCP tool read_document.